Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
8/27/2008 2:22:12 PM
Aug. 27--Sandoz's pill manufacturing plant in Wilson failed to follow safeguards to ensure several of its medicines were made the same way every time. The Food and Drug Administration noted the violations during a two-week inspection in March. Since then, the plant has also failed to properly follow up on the violations, the FDA wrote in a warning letter mailed Aug. 12.
Amylin Pharmaceuticals, Inc.
Eli Lilly and Company
) to Hold Byetta Call After
(NVS) Generic Unit on Plant Problems
510(k) Clearance for TomoDirect(TM) Radiotherapy Technology
AMAG Pharmaceuticals, Inc.
Imaging Agent Gets
(STXS) Magnetic Radio Frequency Guidewire for Peripheral Chronic Total Occlusions
New Drug Rulings May Confuse Investors
Over Oral Contraceptive Drug
Probe Into South Africa Drugs Recall
Barr Pharmaceuticals, Inc.
(BRL) Subsidiary Sues
Watson Pharmaceuticals, Inc.
for SEASONALE(R) Patent Infringement
Advisers Face New U.S. Rules on Industry Ties
comments powered by Disqus.
comments powered by
Food and Drug Administration (FDA)
Biotech/Pharma - Regulatory